Lenalidomide PLX Healthcare Services 2.5 mg

Lenalidomide PLX Healthcare Services 2.5 mg is a medicine authorised by Swissmedic under authorisation number 70462. The authorisation holder is PLX Healthcare Services (Schweiz) GmbH. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 04 June 2026 and the authorisation is limited until 03 June 2031. ATC code L04AX04 places the medicine in the group Immunosuppressants.

  • Dispensing category A
  • Authorisation number 70462
  • ATC L04AX04
  • Synthetic medicines
Authorisation data
Authorisation number70462
NameLenalidomide PLX Healthcare Services 2.5 mg
Full nameLenalidomide PLX Healthcare Services 2.5 mg, Hartkapseln
Authorisation holderPLX Healthcare Services (Schweiz) GmbH
Medicinal product codeSynthetic medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeL04AX04
First authorisation04 June 2026
Authorisation validity03 June 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Lenalidomide PLX Healthcare Services 2.5 mg, HartkapselnA04 June 2026
2Lenalidomide PLX Healthcare Services 5 mg, HartkapselnA04 June 2026
3Lenalidomide PLX Healthcare Services 7.5 mg, HartkapselnA04 June 2026
4Lenalidomide PLX Healthcare Services 10 mg, HartkapselnA04 June 2026
5Lenalidomide PLX Healthcare Services 15 mg, HartkapselnA04 June 2026
6Lenalidomide PLX Healthcare Services 20 mg, HartkapselnA04 June 2026
7Lenalidomide PLX Healthcare Services 25 mg, HartkapselnA04 June 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
121Kapsel(n)L04AX0407.16.4.A
221Kapsel(n)L04AX0407.16.4.A
321Kapsel(n)L04AX0407.16.4.A
421Kapsel(n)L04AX0407.16.4.A
521Kapsel(n)L04AX0407.16.4.A
620Kapsel(n)L04AX0407.16.4.A
721Kapsel(n)L04AX0407.16.4.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Lenalidomide PLX Healthcare Services 2.5 mg authorised in Switzerland?

Yes. Lenalidomide PLX Healthcare Services 2.5 mg is authorised by Swissmedic under authorisation number 70462, data as of 01 September 2026. The authorisation is limited until 03 June 2031.

Which dispensing category does Lenalidomide PLX Healthcare Services 2.5 mg have?

Lenalidomide PLX Healthcare Services 2.5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Lenalidomide PLX Healthcare Services 2.5 mg?

The authorisation holder is PLX Healthcare Services (Schweiz) GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com